We support every step of your ADC discovery program


Scroll to learn more

Antigen Binding Specificity and Potency
ADC molecules must demonstrate the same or similar antigen binding specificity and potency as the unconjugated antibody. We offer advanced solutions to meticulously evaluate and optimize antigen binding properties, ensuring maximum therapeutic benefit.

  • Perform high throughput selectivity / specificity testing using our protein microarrays
  • Determine binding potency using SPR, flow cytometry, and ELISA
  • Evaluate binding residential time (with on/off rate) for your antibody alone and after conjugation, using our state-of-the-art SPR capabilities
  • Characterize surface antigen expression (surfaceome) across 160 cancer cell lines with our OncoFlow-Profiler panel
  • Analyze receptor density by flow, using QIFIKIT

Contact Us